<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231016059744N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-08</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of speech perception training in tinnitus management</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of speech perception in noise training on quality of life in chronic tinnitus sufferers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>28</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73213</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Tinnitus.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: People in the intervention group receive 8 sessions of Word-in-Noise Training (WINT) along with Tinnitus Retraining Therapy (TRT) including counseling and sound therapy. TRT counseling includes explanations about the anatomy and physiology of the normal and damaged auditory system/the role of the central auditory system and higher cortical processes/explanation of Jasterboff's neurophysiological model about tinnitus/the importance of activating the subcortical, limbic and autonomic nervous systems in tinnitus and etc. Sound therapy also includes explaining the importance of sound enrichment, setting up sound generators and explaining their use, evaluating sound generators, etc. The Word-in-Noise Training consists of two tracks. The first track has 600 words in 60 subgroups of 10 words, and the other track has babbling noise of several speakers. In each session, 8 subgroups are presented in different signal-to-noise ratios in such a way that the words in the first subgroup are at the intensity level of 62 dB HL without noise, and the second subgroup with a signal-to-noise ratio of about 12+ dB and in the following subgroups, Each time the noise increases by 2 dB until the signal-to-noise ratio is zero. The duration of each session is 60 minutes, of which 30 minutes are devoted toTinnitus Retraining Therapy and 30 minutes to Word-in-Noise Training. Intervention 2: Control group: People in control group receive 8 sessions of Tinnitus Retraining Therapy (TRT) including counseling and sound therapy. Counseling includes explanations about the anatomy and physiology of the normal and damaged auditory system/the role of the central auditory system and higher cortical processes/explanation of Jasterboff's neurophysiological model about tinnitus/the importance of activating the subcortical, limbic and autonomic nervous systems in tinnitus and etc. Sound therapy also includes explaining the importance of sound enrichment, setting up sound generators and explaining their use, evaluating sound generators, etc. The duration of each session is 30 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Maryam Sadeghijam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Madadkaran St., Shahnazari Ave., Madar Squ., Mirdamad Blvd., Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 2059</telephone>
        <email>sadeghijam.m@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Maryam Sadeghijam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Madadkaran St., Shahnazari Ave., Madar Squ., Mirdamad Blvd., Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 2059</telephone>
        <email>sadeghijam.m@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>People with Subjective and Chronic Tinnitus (with more than 6 months of tinnitus experience)
Normal Pure Tone Hearing Threshold at Frequencies from 250 to 8000 Hz (max. dBHL25)
Normal Results in Tympanometry Test (Type An)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Obtaining more than 11 Score in the Hospital Anxiety and Depression Scale (HADS) questionnaire
History of Exposure to Occupational Noise
History of any Neurological Disease (including History of Head or Neck Injury, Migraine, Multiple Sclerosis, etc.) and Otological Disease (including Otosclerosis, Meniere's, Otitis, etc.)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H93.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Tinnitus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: People in the intervention group receive 8 sessions of Word-in-Noise Training (WINT) along with Tinnitus Retraining Therapy (TRT) including counseling and sound therapy. TRT counseling includes explanations about the anatomy and physiology of the normal and damaged auditory system/the role of the central auditory system and higher cortical processes/explanation of Jasterboff's neurophysiological model about tinnitus/the importance of activating the subcortical, limbic and autonomic nervous systems in tinnitus and etc. Sound therapy also includes explaining the importance of sound enrichment, setting up sound generators and explaining their use, evaluating sound generators, etc. The Word-in-Noise Training consists of two tracks. The first track has 600 words in 60 subgroups of 10 words, and the other track has babbling noise of several speakers. In each session, 8 subgroups are presented in different signal-to-noise ratios in such a way that the words in the first subgroup are at the intensity level of 62 dB HL without noise, and the second subgroup with a signal-to-noise ratio of about 12+ dB and in the following subgroups, Each time the noise increases by 2 dB until the signal-to-noise ratio is zero. The duration of each session is 60 minutes, of which 30 minutes are devoted toTinnitus Retraining Therapy and 30 minutes to Word-in-Noise Training.</i_keyword>
      <i_keyword>Control group: People in control group receive 8 sessions of Tinnitus Retraining Therapy (TRT) including counseling and sound therapy. Counseling includes explanations about the anatomy and physiology of the normal and damaged auditory system/the role of the central auditory system and higher cortical processes/explanation of Jasterboff's neurophysiological model about tinnitus/the importance of activating the subcortical, limbic and autonomic nervous systems in tinnitus and etc. Sound therapy also includes explaining the importance of sound enrichment, setting up sound generators and explaining their use, evaluating sound generators, etc. The duration of each session is 30 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Tinnitus Loudness. Timepoint: Before the intervention and one week after the end of the intervention period. Method of measurement: Visual Analogue Scale (VAS).</prim_outcome>
      <prim_outcome>Tinnitus Annoyance. Timepoint: Before the intervention and one week after the end of the intervention period. Method of measurement: Visual Analogue Scale (VAS).</prim_outcome>
      <prim_outcome>Tinnitus Handicap. Timepoint: Before the intervention and one week after the intervention period. Method of measurement: Tinnitus Functional Index (TFI) Questionnaire.</prim_outcome>
      <prim_outcome>Quality of Life. Timepoint: Before the intervention and one week after the intervention period. Method of measurement: Short Form 12 (SF-12) Questionnaire.</prim_outcome>
      <prim_outcome>Ability to understand speech in noise. Timepoint: Before the intervention and one week after the intervention period. Method of measurement: Quick Speech in Noise Test (Quick SIN).</prim_outcome>
      <prim_outcome>Tinnitus Psychophysical Loudness. Timepoint: Before the intervention and one week after the intervention period. Method of measurement: Loudness Matching Using an Audiometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-04-26</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Iran University of medical Science, Next to Milad Tower, Shahid Hemmat Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
